Dr. Terlinsky Comments of Endo 2015 and Age Management Medical Group Meeting 2015

Having returned from Orlando where the annual meeting of the Age Management Medical Group  has just ended, I was impressed by several presentations. The safety of testosterone replacement in hypogonadal men has recently been raised by two studies over the past 2 years. Before these concerning studies , there had been many positive studies supporting the benefit of middle age and elderly men using testosterone. While both of these recent studies have been critized for poor methodolgy of study design , their combined impact has caused some physicans and the FDA to caution patients about potential adverse  cardiovascular events in older men using testosterone. There are now 4 new studies reported this year  , small in scope, but nevertheless  reassuring that testosterone use is not a cardiovascular risk for men who use it. . I will publish the details in a news article in a few days.

Endo 2015 also had news for women concerninfg the use of hormone replacement therapy and it was also good. A large meta-analysis  looking at the mortality data of women who have used hormone replacement therapy has found no difference in mortality . For those women  who use hormones after menopause for “quality of life ” reasons this is very reassuring . I will also discuss this study in detail in anothger news article.

I have been to the American Academy of Anti-aging and Restorative Medicine in Las Vegas in December 2014 and now the Age Mangement Medical Group and the themes at both meeting stress the emerging topic of how clinical genomics, nutrition , hormone balance, detoxification promote healthy aging. More comments on this to follow.